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XCoe2, a transcription factor of the Col/Olf-1/EBF family
involved in the specification of primary neurons in Xenopus
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Laurent Paquereau* and Alain Vincent*
Background: Primary neurogenesis in Xenopus is a model for studying the
control of neural cell fate decisions. The specification of primary neurons
appears to be driven by transcription factors containing a basic region and a
helix–loop–helix (HLH) motif: expression of Xenopus neurogenin-related-1 
(X-ngnr-1) defines the three prospective domains of primary neurogenesis, and
expression of XNeuroD coincides with neuronal differentiation. The transition
between neuronal competence and stable commitment to a neuronal fate
remains poorly characterised, however.
Results: Drosophila Collier and rodent early B-cell factor/olfactory-1 define a
family of HLH transcription factors containing a previously unknown type of
DNA-binding domain. We isolated an orthologous gene from Xenopus, Xcoe2,
which is expressed in precursors of primary neurons. Xcoe2 is transcribed after
X-ngnr-1 and before XNeuroD. Overexpression of a dominant-negative mutant
of XCoe2 prevented neuronal differentiation. Conversely, overexpressed wild-
type Xcoe2 could promote ectopic differentiation of neurons, in both the neural
plate and the epidermis. In contrast to studies with X-ngnr-1 or XNeuroD, the
supernumerary neurons induced by Xcoe2 appeared in a ‘salt-and-pepper’
pattern, resulting from the activation of X-Delta1 expression and feedback
regulation by lateral inhibition.
Conclusions: XCoe2 may play a pivotal role in the transcriptional cascade that
specifies primary neurons in Xenopus embryos: by maintaining Delta–Notch
signalling, XCoe2 stabilises the higher neural potential of selected progenitor
cells that express X-ngnr-1, ensuring the transition between neural competence
and irreversible commitment to a neural fate; and it promotes neuronal
differentiation by activating XNeuroD expression, directly or indirectly.
Background
Neural development in vertebrates starts during gastrula-
tion with the demarkation of the neural plate, which is ini-
tially a field of undifferentiated, mitotically active cells. In
anamniotic vertebrates such as Xenopus or the zebrafish, a
first wave of cells withdraws from the mitotic cycle early
during embryogenesis to generate a simple pattern of
primary neurons that control early larval behaviour [1]. This
early and precisely scheduled pattern makes primary neu-
rogenesis in Xenopus an attractive model for the study of
molecular and cellular mechanisms involved in neural cell
fate decisions. Xenopus studies have shown that despite the
gross anatomical and developmental differences between
the vertebrate and Drosophila central nervous systems
(CNSs), remarkably similar sets of genes and mechanisms
are involved in neurogenesis in the two species [2,3].
The genetic control of neuroblast formation has been
studied in considerable detail in Drosophila. Expression of
a group of regulatory genes, the proneural genes, which
encode transcription factors containing a basic region asso-
ciated with a helix–loop–helix dimerisation motif (bHLH
factors), is believed to render groups of cells competent to
form neuronal progenitors. The selection of neuronal
progenitors from each group of competent cells involves
lateral inhibition, a cell–cell signalling mechanism by
which cells committed to differentiate force neighbouring
cells to remain uncommitted [2,4]. In this process, the
inhibitory signal Delta emitted by the nascent neural cells
activates its transmembrane receptor Notch on adjacent
cells [5]. Whereas the early action of proneural genes pro-
motes the expression of Delta, expression of the
proneural genes is down-regulated by activated Notch
[6,7]. It has been proposed that this feedback mechanism
magnifies the small differences between adjacent cells in
their levels of proneural gene expression; cells initially
expressing higher levels of proneural activity than their
neighbours become less sensitive to lateral inhibition and
are consequently committed to a neural fate [8]. The
nature of the events that stabilise neural fate and commit
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a cell irreversibly to neuronal differentiation have not yet
been completely elucidated, however.
In Xenopus, the neuronal progenitors that give rise to the
primary (larval) nervous system form in the neural plate in
three longitudinal domains — medial, intermediate and
lateral. The generation of these neurons is regulated by
lateral inhibition mediated by Delta–Notch signalling in
the same way as in Drosophila. Two recently identified
bHLH transcription factors, Xenopus neurogenin-related-1
(X-Ngnr-1) and XNeuroD, are expressed in the progenitors
of primary neurons [9,10]. Expression of the X-ngnr-1 gene
defines the three prospective domains of primary neuroge-
nesis, and X-ngnr-1 has been proposed to act as a neuronal
determination gene, perhaps analogous to the Drosophila
proneural genes, whereas XNeuroD appears to act later, in
the neuronal differentiation of committed cells. The tem-
poral separation between X-ngnr-1 expression and the acti-
vation of XNeuroD suggested that intermediate factors in
the cascade of transcriptional activation specifying the
primary neuron progenitors were yet to be identified [10].
We have cloned the Xenopus gene Xcoe2, which encodes a
different transcription factor involved in the neurogenic
cascade, by means of its homology to the rodent early B-
cell factor/olfactory-1 (EBF/Olf-1) and Drosophila Collier
(Col) transcription factors. The col gene was isolated as a
regulator of Drosophila head patterning [11], and EBF/Olf-
1 was characterised independently both as a B-cell-spe-
cific factor (EBF [12]) and as an olfactory-neuron-specific
factor (Olf-1 [13]). These proteins define a family of tran-
scription factors with a type of DNA-binding domain asso-
ciated with a HLH motif [11,14] that had not been
described previously. Two additional mouse genes of the
same family have been identified recently: EBF-
2/OE3/Mmot1 and EBF-3/OE2 [15–17]. Although slightly
different results were reported concerning the respective
timing and specificity of expression of each mouse
EBF/OE gene, all three genes are transiently expressed in
a subset of precursor cells in the embryonic CNS and the
peripheral nervous system, concomitantly with the initia-
tion of overt differentiation within the nervous system
[15–17]. We have turned to the Xenopus embryo in order to
investigate the early embryonic functions of the Col/Olf-
1/EBF family of transcription factors. We show here that
XCoe2, the homologue of EBF-2, is an essential compo-
nent of primary neurogenesis in Xenopus, perhaps acting to
connect X-Ngnr-1 and XNeuroD functions.
Results
Identification and embryonic expression of a Xenopus
gene related to Drosophila collier and mouse EBF
To isolate Xenopus embryonic cDNAs related to the
Drosophila collier and mouse EBF genes, we performed
reverse transcriptase PCR using cDNAs from stage 25
embryos and degenerate oligonucleotide primers derived
from conserved sequences flanking the DNA-binding
domain of Col and EBF/Olf-1. (The same strategy, ampli-
fying related sequences in the mouse, led to the isolation
of EBF-2 and EBF-3 [15].) DNA fragments of the
expected size (560 bp) were amplified and cloned in bac-
teria. Analysis of 11 independent clones revealed coding
sequences highly related to the Col/EBF DNA-binding
domain although differing from each other at a few posi-
tions specific to each clone. Three of the eleven clones
were identical, and the cDNA thus defined was used to
probe a northern blot containing RNA from Xenopus
embryos at different developmental stages. A single tran-
script, about 3 kb in length, was detected in neurula-stage
embryos (data not shown). The same fragment was there-
fore used to screen a cDNA library from stage 17 Xenopus
embryos [18]. Of 106 phages tested, six positive clones
were isolated, differing only by the length of their 5′ ends.
Comparison between the largest cDNA obtained and the
products of rapid amplification of cDNA ends (RACE)
indicated that it was full length. Hybridisation of this
cDNA clone to a developmental northern blot confirmed
the zygotic expression of a 3 kb transcript, with expression
starting at the neural plate stage and with a peak of tran-
script accumulation at the tailbud stage. A transcript of the
same size was also detected in a subset of adult tissues: at
high levels in the brain and low levels in the somatic
muscles, testis, and possibly the spleen (Figure 1a and
data not shown). Nucleotide sequencing revealed an open
reading frame of 1767 nucleotides, predictive of a 589
amino-acid protein (Figure 1b) highly related to Col and
EBF/Olf-1. We named this gene Xcoe2 (Xenopus member
of the Col/Olf-1/EBF family of transcription factors).
Sequence alignment between XCoe2, Col, EBF, EBF-2
and EBF-3 (data not shown) confirmed the presence of
two particularly well-conserved regions corresponding to
the DNA-binding domain and the dimerisation domain,
which includes an HLH motif (Figure 1b) [11]. XCoe2
appears, however, more closely related to EBF-2 than to
either EBF or EBF-3, hence the suffix 2.
Comparison of the Col, EBF and XCoe2 amino-acid
sequences with other protein sequences in the current
databases revealed an extensive similarity with a predicted
Caenorhabditis elegans open reading frame, which probably
corresponds to the protein product of the unc-3 gene, origi-
nally identified in the genetic screen of S. Brenner [19]
(T. Starrich, personal communication). A comparison of
the predicted DNA-binding domains of Col, EBF and
XCoe2 shows a small stretch of two or three amino-acid
residues (boxed in Figure 1b), specific to each protein,
that might be considered a gene-specific ‘signature’. The
same signature was present in all 11 PCR products ampli-
fied from stage 25 Xenopus embryos, suggesting that
during primary neurogenesis in Xenopus Xcoe2 is the most
highly, if not the only, expressed coe gene.
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Xcoe2 is an early marker of primary neurogenesis
To examine the role of Xcoe2 in Xenopus embryos, we
first analysed its early embryonic expression by whole-
mount in situ hybridisation. Xcoe2 transcripts were first
detected at the open neural-plate stage (stage 12), in a
pattern anticipating that of the neuron-specific N-tubulin
gene (Figure 2a; see also Figure 3). N-tubulin expression
was previously shown to mark the formation of three
groups of primary neurons, arranged in a radially sym-
metrical pattern on either side of the dorsal midline, in
the posterior neural plate. The medial (future ventral),
intermediate and lateral (future dorsal) groups of neurons
will later differentiate into motorneurons, interneurons
and sensory neurons, respectively. Expression of Xcoe2
completely overlapped that of N-tubulin at stage 13, and
this overlap included expression in the trigeminal pla-
codes (Figure 2a). Xcoe2 is therefore a new early marker
of primary neurogenesis. At around stage 17, Xcoe2 began
to be expressed in groups of anterior cells associated with
the olfactory placodes, and in prospective anterior neural
crest cells (Figure 2b). When the neural tube closed, Xcoe2
expression in the spinal cord was restricted to the lateral
zone, being absent from the mitotically active ventricular
zone (Figure 2c), as has already been observed for mouse
EBF-2 [15]. From stage 28, this expression faded gradu-
ally, in an antero-posterior gradient, to become unde-
tectable at stage 32 (compare Figure 2d and 2e). These
observations show that Xcoe2 is expressed only transiently
in post-mitotic neurons. 
Between stages 20 and 28, neural crest cells contributing
to the mandibular, hyoid and third branchial arches
express Xcoe2 (Figure 2d,e). These cells, which migrate
ventrally between the ectoderm and the dorsal mesoderm,
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Figure 1
(a) A profile of Xcoe2 transcript accumulation
during development and in adult tissues. A
northern blot containing RNA from different
developmental stages was probed with
labelled 2.2 kb Xcoe2 cDNA. The
developmental stage of each embryonic RNA
is indicated. No hybridisation signal was
detected with RNA from oocytes at any stage
of oogenesis (data not shown). A 3 kb Xcoe2
transcript is present in embryos starting at the
neural plate stage. A transcript of the same
size is detected in specific adult tissues and is
most abundant in muscle, testis and brain.
Each lane contains 10 µg total RNA. We used
ribosomal RNA, visualised by ethidium
bromide staining, as an internal standard for
quantification of deposited RNA (data not
shown). MBT, mid-blastula transition. (b)
Amino-acid sequence alignment of Xenopus
XCoe2 with other members of the EBF/Col
family: mouse EBF and EBF2 and Drosophila
Col. Identical and similar amino acids are
indicated by blue and grey shading,
respectively. The DNA-binding domain,
framed by open arrowheads, extends from
EBF/Olf-1 amino acids 50 to 251 and
includes a zinc-binding motif (amino acids
151–177). The second highly conserved
domain is framed by black arrowheads. The
horizontal arrows indicate the positions of
helix 1 and helix 2 of a predicted HLH motif
which is conserved in all four proteins; a
duplicated helix 2 (labelled 2′) is present in
the vertebrate proteins. A stretch of two or
three amino acids specific to each protein is
boxed. Dashes represent spaces to optimise
the alignment. 
XCoe2    1 MFGVQETFG---TALRDKALGVGMDPVRSWVRNVGVVDAKVAAQSGVAVSRAHFEKQPPSNLRKSNFFHFVLALYDRQGQPIEIERTSFV
mEBF2    1 MFGIQDTLGR-GPALKDKSLGAPRWIRSGPGSGMSAWWANVAAQSGVALSRAHFEKQPPSNLRKSNFFHFVLALYDRQGQPVEIERTAFV
mEBF     1 MFGIQESIQRSGSSMKEEPLGSGMNAVRTWMQGAGVLDANTAAQSGVGLARAHFEKQPPSNLRKSNFFHFVLALYDRQGQPVEIERTAFV
DCol     1 MFGLPPTAAVDMNQPRGPMTSLKEEP-----LGSRWAMQPVVDQSNLGIGRAHFEKQPPSNLRKSNFFHFVIALYDRAGQPIEIERTAFI
XCoe2   88 DFVENEKEFSTEKTNNGTHYKLQLLYSNGVRTEQDLYVRLIDSVTKQPISYEGQNKNPEMCRVLLTHEVMCSRCCEKKSCGNRNETPSDP
mEBF2   90 DFVENDKEQGNEKTNNGTHYKLQLLYSNGVRTEQDLYVRLIDSVTKQPIAYEGQNKNPEMCRVLLTHEVMCSRCCEKKSCGNRNETPSDP
mEBF    91 GFVEKEKEANSEKTNNGIHYRLQLLYSNGIRTEQDFYVRLIDSMTKQAIVYEGQDKNPEMCRVLLTHEIMCSRCCDKKSCGNRNETPSDP
DCol    86 GFIEKDSESDATKTNNGIQYRLQLLYANGARQEQDIFVRLIDSVTKQAIIYEGQDKNPEMCRVLLTHEVMCSRCCDKKSCGNRNETPSDP
XCoe2  178 VIIDRFFLKFFLKCNQNCLKTAGNPRDMRRFQVVLSTTVNVDGHVLAVSDNMFVHNNSKHGTRARRLDPSE-------------------
mEBF2  180 VIIDRFFLKFFLKCNQNCLKTAGNPRDMRRFQVVLSTTVNVDGHVLAVSDNMFVHNNSKHGRRARRLDPSE-------------------
mEBF   181 VIIDRFFLKFFLKCNQNCLKNAGNPRDMRRFQVVVSTTVNVDGHVLAVSDNMFVHNNSKHGRRARRLDPSEGT-----------------
DCol   176 VIIDRFFLKFFLKCNQNCLKNAGNPRDMRRFQVVISTQVAVDGPLLAISDNMFVHNNSKHGRRAKRLDTTEGTGNTSLSISGHPLAPDST
XCoe2  249 ----------ATPCIKAISPSEGWTTGGAMVIIIGDNFFDGLQVEFGTMLVWSELMTPHAIRVQTPPRHIPGVVEVTLSYKSKQFCKGAP
mEBF2  251 ----------ATPCIKAISPSEGWTTGGAMVIIIGDNFFDGLQVVFGTMLVWSELITPHAIRVQTPPRHIPGVVEVTLSYKSKQFCKGAP
mEBF   254 ----PSYLEHATPCIKAISPSEGWTTGGATVIIIGDNFFDGLQVIFGTMLVWSELITPHAIRVQTPPRHIPGVVEVTLSYKSKQFCKGTP
DCol   266 YDGLYPPLPVATPCIKAISPSEGWTTGGATVIIVGDNFFDGLQVVFGTMLVWSELITSHAIRVQTPPSDIPGVVEVTLSYKSKQFCKGSP
XCoe2  329 GRFIYT-ALNEPTIDYGFQRLQKVIPRHPGDPERMAKEMLLKRAADLVEALYGTPHNNQDIILKRAADIAEALYSVPRNHNQIPALSSSP
mEBF2  331 GRFIYT-ALNEPTIDYGFQRLQKVIPRHPGDPERLAKEMLLKRAADLVEALYGTPHNNQDIILKRAADIAEALYSVPRNPSQIPALSSSP
mEBF   340 GRFIYT-ALNEPTIDYGFQRLNKVIPRHPGDPERLPKEVILKRAADLVEALYGMPHNNQEIILKRAADIAEALYSVPRNHNQLPALANTS
DCol   356 GRFVYVSALNEPTIDYGFQRLQKLIPRHPGDPEKLQKEIILKRAADLVEALYSMPRS--P----------------------D-------
XCoe2  418 VHSGMMGINSYGGQLGVSISESQ--ANNQGYIRN-TSSISPRGYSSSSTPQQSNYSTPSNSMNGYSKVPMSNLGVPGSPGFINGSPTTSP
mEBF2  420 AHSGMMGINSYGSQLGVSISESTQ-GNNQGYIRN-TSSISPRGYSSSSTPQQSNYSTSSNSMNGYSNVPMANLGVPGSPGFLNGSPTGSP
mEBF   429 VHAGMMGVNSFSGQLAVNVSEASQ-ATNQGFTRN-SSSVSPHGYVPSTTPQQTNYNSVTTSMNGYGSAAMSNLGG--SPTFLNGSAANSP
DCol   415 ---GSTGFNSYAGQLAVSVQDGSGQWTEDDYQRAQSSSVSPRGG----------YCSSASTPHSSGGSYGATAASAAVAATANGYAPAPN
XCoe2  505 YGIMPSSPPVGS--------SGSSSILPFS-SSVFPSIKQKSGLCPCHTTQGSPSPACSSSNSNGFRENLLKDSPAMRQGQYFAQCSNPS
mEBF2  508 YGIMSSSPTVGS--------SSTSSILPFS-SSVFPAVKQKSAFAPVIRPQGSPSPACSSGNGNGFRAMTGLVVPPM-------------
mEBF   515 YAIVPSSPTMASSTSLPSNCSSSSGIFSFSPANMVSAVKQKSAFAPVVRPQTSPPPTCTSTNGNSLQAISGMIVPPM-------------
DCol   492 MGTLSSSP--GS--------VFNSTSMSAVSSTWHQAFVQHHHAATAHPHHHYPHPHQPWHNPAVSAATAAAV-----------------
XCoe2  586 VGFW
mEBF2      ----
mEBF       ----
DCol       ----
1 2   2'
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may participate in the formation of the cartilaginous skele-
ton [20]. Other Xcoe2-expressing neural crest cells will
contribute to the cranial ganglia. At stage 32, Xcoe2 expres-
sion remained strong in specific groups of cells in the mes-
encephalon and the rhombencephalon where neuronal
differentiation was still proceeding, and in the olfactory
placodes and cranial ganglia (Figure 2e). Xcoe2 expression
in early embryos was not restricted to neurectodermal
cells, but also occurred transiently in cells located at the
border between somites and lateral plates before these
two mesodermal derivatives become separate (Figure 2d
and data not shown). 
Xcoe2 expression follows X-ngnr-1 and X-Dl1 but precedes
N-tubulin and XNeuroD 
On the basis of its early expression in the neural plate and
its regulation by lateral inhibition, X-ngnr-1 has been pro-
posed to be a proneuronal-like gene, encoding a protein
that functions, at least in part, to activate X-Delta-1 (X-
Dl1) and neural differentiation genes such as N-tubulin
and XNeuroD [10]. In order to investigate further the pos-
sible function of Xcoe2 during primary neurogenesis, we
compared in detail its temporal pattern of expression rela-
tive to the expression of these other genes. The earliest
expression of Xcoe2 occurs at stage 12, after X-Dl1 and X-
ngnr-1 expression has become restricted to the prospec-
tive neuronal progenitors by lateral inhibition (Figure 3a)
[10,21]. Xcoe2 expression anticipates the pattern of all
primary neurons as marked by N-tubulin expression at
stage 12.5. It also anticipates the expression of XNeuroD,
which is not detected prior to stage 13.5, and then only in
a subset of cells expressing Xcoe2 and X-ngnr-1 ([9,10] and
data not shown). The sequential order of transcription of
the known HLH transcription factors involved in Xenopus
primary neurogenesis therefore starts with X-ngnr-1, fol-
lowed by Xcoe2 and then, significantly later, XNeuroD. In
order to determine whether Xcoe2 expression was con-
trolled by X-ngnr-1, we injected X-ngnr-1 mRNA into one
blastomere of embryos at the two-cell stage and looked at
Xcoe2 mRNA at developmental stage 14 by in situ
hybridisation. A lacZ mRNA marker was co-injected and
the distribution of β galactosidase activity was used to
assess the distribution of the injected mRNAs. All 26
injected embryos examined showed ectopic Xcoe2 mRNA
on the injected side, in both the neural plate and the epi-
dermis, indicating that X-ngnr-1 ectopically activates
Xcoe2 transcription (Figure 3b). Together, the temporal
and spatial expression of Xcoe2 and its activation by X-
ngnr-1 suggested that Xcoe2 acts at an early stage in the
neurogenic cascade, upstream of neuronal differentiation
genes such as XNeuroD.
Decreasing XCoe2 activity prevents neuronal specification
To determine whether Xcoe2 is required for the specifica-
tion of primary neurons, we attempted to decrease XCoe2
activity in embryos by overexpressing a dominant-nega-
tive mutant form of the protein. The design of this
mutant protein, XCoe2∆DBD, was based on the functional
dissection of the EBF/Olf-1 protein in vitro [12,14] and on
the high structural conservation of the dimerisation region
and DNA-binding domain in all members of the Coe
family (Figure 1b). XCoe2∆DBD has a truncation that
removes the DNA-binding domain but leaves the dimeri-
sation domain intact (Figure 4a). We hypothesised that
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Figure 2
Xcoe2 mRNA expression during Xenopus
development, revealed by whole-mount in situ
hybridisation. Embryos at stages (a) 14, (b)
17, (c,d) 28 and (e) 32 are shown. Anterior is
to the left; (a,b) dorsal view; (d,e) lateral view.
The three stripes of primary neuron
precursors, medial (m), intermediate (i) and
lateral (l) and the trigeminal ganglia (tg), are
indicated. In (b), the positions of nascent
olfactory placodes (op; arrowhead) and
anterior neural crest cells (nc) are also
indicated. (c) Transverse section at the level
of the spinal cord (sc). Xcoe2 expression is
restricted to differentiating neurons in the
marginal zone. This expression is still
observed at stage 28 (d) but no longer at
stage 32 (e). Other abbreviations: c, cartilage;
ha, hyoid arch; ms, mesencephalon; mz,
marginal zone; n, notocord; rh,
rhombencephalon; vz, ventricular zone.
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(e)
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overexpressing this truncated protein would titrate the
native XCoe2 and prevent its normal function via the for-
mation of XCoe2–XCoe2∆DBD heterodimers that are not
able to bind DNA properly [12]. Xcoe2∆DBD and lacZ
mRNAs were injected into embryos at the four-cell stage.
As a result, cells expressing N-tubulin or X-NeuroD were
absent or drastically reduced in number in the regions of
the embryo expressing injected mRNA, as defined by
staining for β-galactosidase activity (compare Figure 4b
and c,d; 74% (n = 65) and 72% (n = 36) of embryos have
reduced numbers of cells expressing N-tubulin and
XNeuroD, respectively). This effect was completely
reversed when mRNA encoding full-length XCoe2 was
co-injected with Xcoe2∆DBD mRNA (data not shown), indi-
cating that XCoe2∆DBD specifically antagonises XCoe2
activity. In order to determine at which stage XCoe2∆DBD
blocked the neuronal determination process, we exam-
ined the patterns of expression of X-ngnr-1 at stages 11.5
and 14, and activation of endogenous Xcoe2 at stage 12,
using the 5′-specific probe defined in Figure 4a. Normal
patterns of X-ngnr-1 and Xcoe2 expression were observed
at stage 11.5–12, (Figure 4e,g; 100% of embryos, n = 26,
expressed X-ngnr-1 in a normal pattern, 84%, n = 49,
expressed Xcoe2 in a normal pattern), indicating that
XCoe2∆DBD blocks the neuronal specification process
only after the onset of endogenous Xcoe2 expression. We
noted a significant reduction of X-ngnr-1 expression as
early as stage 12.5 on the injected side in 65% of embryos
(n = 40), however, suggesting that XCoe2 activity is
required to maintain X-ngnr-1 transcription in selected
progenitor cells (Figure 4f). When embryos injected with
Xcoe2∆DBD mRNA reached the tadpole stage, most did not
show a proper escape response, being unable to contract
on one side, a phenotype suggestive of unilateral innerva-
tion defects. Given also the sequence of expression 
X-ngnr-1, Xcoe2 and XNeuroD, the block of neuronal diff-
erentiation resulting from overexpression of XCoe2∆DBD
suggests that XCoe2 is essential for the specification of
primary neurons in the Xenopus embryo, acting down-
stream of X-ngnr-1 and upstream of XNeuroD. It may act
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Figure 3
X-Dl1, Xcoe2 and N-tubulin are activated sequentially in prospective
primary neurons. (a) Expression of X-Dl1, Xcoe2 and N-tubulin during
early Xenopus embryogenesis was analysed by whole-mount in situ
hybridisation. Probes and stages of embryonic development are
indicated. All embryos are shown in a dorsal view, with the anterior to
the top. The three stripes of primary neurons, medial (m), intermediate
(i) and lateral (l), are indicated. (b) One cell (inj) of an embryo at the
two-cell stage was injected with synthetic X-ngnr-1 (10 pg) and lacZ
(50 pg) mRNAs. In situ hybridisation to a stage 14 embryo with a
probe to Xcoe2 shows the ectopic activation of Xcoe2 by X-Ngnr-1.
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Figure 4
Xcoe2 is required for the differentiation of primary neurons in the
Xenopus embryo. (a) The epitope-tagged deletion mutant Xcoe2∆DBD
was constructed by removing the region encoding the DNA-binding
domain (grey) almost entirely and leaving the homodimerisation domain
(blue) intact [14]. The c-Myc epitope tag of Xcoe2∆DBD is indicated
(black) at the amino terminus. Embryos were microinjected with the
following mRNAs: (b) lacZ (500 pg) or (c–g) lac Z (50 pg) and
Xcoe2∆DBD (500 pg), followed by in situ hybridisation of embryos at
stage 13.5–14 with either (b,c) N-tubulin probe, or (d) X-NeuroD
probe; embryos at (e) stage 11.5 and (f) stage 13 with X-ngnr-1
probe; and (g) embryos at stage 12 with a 5′ Xcoe2 probe, indicated
in (a), that does not hybridise to Xcoe2∆DBD mRNA. All embryos are
shown in a dorsal view with the injected side on the right.
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partly through a positive-feedback regulation of X-ngnr-1
expression in selected progenitor cells.
Ectopic Xcoe2 induces ectopic neurogenesis in only
scattered cells of both the neural plate and the epidermis
The results described above suggest that XCoe2 is neces-
sary for primary neurogenesis, so we next asked whether
XCoe2 is sufficient to induce ectopic neurogenesis. Xcoe2
was overexpressed in Xenopus embryos by injecting Xcoe2
mRNA (together with lacZ mRNA) at the two-cell or four-
cell stage. The pattern of neurogenesis in Xcoe2-injected
embryos was examined at various intervals by in situ
hybridisation with probes for XNeuroD and N-tubulin.
Overexpression of Xcoe2 mRNA caused ectopic neurogen-
esis both within the neural plate and in regions of pre-
sumptive epidermis. At stage 15–16, scattered cells on the
injected side appeared to express XNeuroD (Figure 5a,c;
65% of embryos, n = 48) or N-tubulin (71% of embryos,
n = 70, data not shown) in the neural plate and epidermis,
whereas the three stripes of primary neurogenesis were
normal on the uninjected side (Figure 5a). Because
Xcoe2∆DBD injection experiments indicated a feedback reg-
ulation of X-ngnr-1 transcription by Xcoe2 after stage 12, we
examined X-ngnr-1 expression in Xcoe2-injected embryos.
Figure 5b shows that X-ngnr-1 is ectopically activated in
response to Xcoe2 RNA overexpression and, as observed
with XNeuroD, in a scattered cell pattern (86% of embryos,
n = 36). At the tailbud stage (stage 25), cells expressing N-
tubulin or XNeuroD ectopically were still observed within
the epidermis (Figure 5c and data not shown). We verified
that some of these cells differentiated into neurons by
staining stage 30 embryos with antibodies directed against
the neural cell adhesion molecule (N-CAM), a general
marker of neural tissue that remains expressed during ter-
minal neuronal differentiation (Figure 5d,e). Differenti-
ated neurons with axonal projections were observed in the
epidermis on the injected side of the embryo, confirming
that Xcoe2 overexpression is sufficient to promote neuronal
fate in ectoderm that is normally non-neurogenic.
The pattern of Xcoe2-induced ectopic neurons results from
the ectopic activation of X-Dl1 and lateral inhibition
Whereas in embryos injected with either X-ngnr-1 mRNA
or X-NeuroD nearly all cells of the neural plate on the
injected side expressed N-tubulin [10], in embryos injected
with Xcoe2 mRNA, cells expressing X-ngnr-1, N-tubulin or
XNeuroD always appeared scattered (Figure 5). This salt-
and-pepper pattern suggested that Xcoe2 neural function is
regulated by lateral inhibition. As X-Dl1 is not expressed
in the epidermis (Figure 3a) [21], we first tested whether
Xcoe2 activates X-Dl1 transcription. In situ hybridisation of
embryos injected with Xcoe2 mRNA showed that X-Dl1
was ectopically expressed in the epidermis by stage 12.5
in 65% of embryos (n = 109). In contrast to X-ngnr-1,
XNeuroD or N-tubulin (Figure 5), X-Dl1 appeared to be
ectopically activated more or less uniformly in all cells in
the region of injection (Figure 6a). The ectopic X-Dl1
transcripts became redistributed into patches of clustered
cells during the developmental period between stages 14
and 17 (Figure 6b). 
Although we have not investigated this patching in more
detail, we noted that, during the same period, cells
expressing ectopic N-tubulin or X-NeuroD (Figure 5c and
data not shown) also redistributed into small patches
(Figure 6c). Furthermore, in situ hybridisation with a com-
bination of X-Dl1 and N-tubulin probes showed that the
N-tubulin-positive cells were mostly located within the
patches of X-Dl1-expressing cells, but only at the border
with cells that did not express X-Dl1 (Figure 6c). This
was consistent with the observation that production of
primary neurons is inhibited when all cells are artificially
caused to express X-Dl1 [21]. The scattered distribution
of Xcoe2-induced neurons indicates that Xcoe2 neural
function is regulated by lateral inhibition. This regulation
occurs in the epidermis as a result of ectopic activation of
X-Dl1 expression by injected Xcoe2. The sensitivity of
Xcoe2 neural function to lateral inhibition was confirmed
by co-injecting into embryos Xcoe2 mRNA and an mRNA
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Induction of ectopic neurogenesis by injection of Xcoe2 mRNA.
Ectopic neurogenesis was visualised by whole-mount in situ
hybridisation using either (a,c) XNeuroD or (b) X-ngnr-1 probes on
embryos at (a,b) stage 15 and (c) stage 25 or (d,e) immunostaining
stage 30 embryos with anti-N-CAM antibodies. Embryos were
microinjected with Xcoe2 (400 pg) and lacZ (50 pg) mRNAs on one
side (inj), and the other side was used as a control. An enlargement of
the box in (d) is shown in (e).
encoding a dominant-negative form of X-Dl1 (X-Dl1stu,
renamed X-Dl1dn) [21,22]. Co-expression of Xcoe2 and X-
Dl1stu resulted in a dramatic increase in both the pene-
trance of ectopic neurogenesis (93% of embryos; n = 46)
and the density of supernumerary neurons induced by
Xcoe2 in both the neural plate and the epidermis (compare
Figure 6d and e), whereas injections of X-Dl1dn alone lead
to supernumerary neuron formation only in the neural
plate (Figure 6f) [21]. We conclude from these experi-
ments that Xcoe2 positively regulates the transcription of
XDl1, and that its ability to drive neuronal differentiation
is highly sensitive to lateral inhibition (Figure 7).
Discussion
In this report, we have investigated the role of XCoe2, an
HLH transcription factor of a new type, in the specifica-
tion of primary neurons in the Xenopus embryo. Results
from both gain-of-function and loss-of-function experi-
ments lead us to propose that Xcoe2 is required for the
stable commitment of selected progenitor cells to a
neural fate. XCoe2 acts downstream of X-ngnr-1 to main-
tain both Delta–Notch signalling and high levels of X-
ngnr-1 expression in selected progenitor cells and is
required for the activation of neural differentiation genes
such as XNeuroD.
XCoe2, an HLH factor in the transcriptional activation
cascade controlling primary neurogenesis
Xcoe2 is transiently expressed in differentiating primary
neurons and is both necessary for primary neurogenesis
and able to convert epidermal cells into neurons. Tempo-
rally, Xcoe2 is activated after X-ngnr-1 and before XNeuroD
in spatially overlapping patterns within the three prospec-
tive areas of primary neurogenesis. Gain-of-function
experiments show that X-ngnr-1 is able to activate the
transcription of Xcoe2, and Xcoe2 can in turn activate X-Dl1
and XNeuroD, as well as X-ngnr-1, in a positive-feedback
mechanism. Conversely, in the presence of a dominant-
negative mutant form of XCoe2, the selected progenitor
cells which express Xcoe2 lose X-ngnr-1 expression and do
not commit to a neural fate. Together, these results
suggest that Xcoe2 plays a pivotal role during primary neu-
rogenesis in enforcing X-ngnr-1 proneural function and in
promoting neuronal differentiation of committed cells by
activating the expression of genes such as XNeuroD either
directly or indirectly (perhaps through the maintenance of
X-ngnr-1 expression). Activation of Xcoe2 occurs at stage
12, whereas XNeuroD transcripts accumulate from stage
13.5 ([9,10,23] and this report). The time window between
activation of Xcoe2 and XNeuroD, during which the vast
majority of primary neuron progenitors are in the last G2
phase preceding their exit from the mitotic cycle [1],
might allow specified neuronal progenitors to interact with
spatio-temporally regulated signals in their microenviron-
ment, and to adopt the fate they will express post-mitoti-
cally, in a cell-autonomous manner.
From selection to differentiation of primary neural
progenitors
Expression of the proneural achaete-scute complex (AS-C)
genes in the Drosophila neurectoderm defines domains
in which all cells are competent to become neuroblasts,
as revealed in neurogenic mutants [24]. Only a selected
number of these cells do, however, become irreversibly
committed to a neural fate. Whereas the transcriptional
feedback loop involving Notch–Delta signalling may not
provide the main mechanism of neuroblast selection, it
is required for the refinement/maintenance of this selec-
tion process so as to ensure the segregation of the correct
number of neuroblasts at the right time and position
[25]. This, together with experiments in Xenopus
embryos and retinae and the embryonic chick retina,
indicates that Delta–Notch signalling regulates the pro-
portion of progenitors that become committed to the
neuronal fate [22,25–27]. 
Whereas expression of the proneural-type gene X-ngnr-1
makes a cell competent to become a neuronal progenitor,
the factors that stabilise the competent state and control
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Figure 6
Xcoe2 ectopically activates, and is regulated by, lateral inhibition. One
cell of a Xenopus embryo at the two-cell or four-cell stage was injected
with (a–d) XCoe2 (400 pg) and lacZ (50 pg) mRNAs; a combination
of (e) XCoe2 (10 pg), X-Dl1dn (400 pg) and lacZ (50 pg) mRNAs; or
(f) X-Dl1dn (400 pg) and lacZ (50 pg) mRNAs, as indicated. Injected
embryos at (a) stage 12.5, (b,c) stage 17 or (d–f) stage 13.5–14 were
hybridised with (a,b) X-Dl1 probe, (c) a combination of X-Dl1 and N-
tubulin probes or (d–f) N-tubulin probe alone as indicated. (a–c)
Lateral view, the injected side is shown. (d–f) Dorso-lateral view, the
injected side is indicated (inj). Ectopic X-Dl1 expression is fairly
uniform at stage 12.5 on the injected side, inj (a), and concentrates in
patches of cells at stage 17 (b). At stage 17 (c), ectopic N-tubulin
expression (dark blue staining) occurs specifically at the periphery of
X-Dl1 positive patches (red staining).
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X-Delta-1 X-Delta-1
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the transition between competence and irreversible com-
mitment to become a primary neuron remained to be
defined [10]. That XCoe2 is such a factor is supported by
several lines of evidence. First, Xcoe2 is required for the
maintenance of X-ngnr-1 expression in selected progenitor
cells during their transition from selection to differentia-
tion. Second, Xcoe2 is able to activate X-Dl1 expression.
Third, its ability to ectopically activate X-ngnr-1 and
XNeuroD in only scattered cells indicates that its neural-
promoting function is highly sensitive to lateral inhibition.
The difference between the patterns of X-Dl1 and X-ngnr-
1 expression also indicates that X-Dl1 activation is a
primary response to XCoe2 overexpression rather than a
secondary response mediated by X-Ngnr-1. This genetic
interaction between Xcoe2 and Delta–Notch signalling was
confirmed by the increased density of ectopic neurons
induced by overexpressed Xcoe2 in the presence of a dom-
inant-negative form of X-Dl1, X-Dl1dn, which renders cells
‘deaf’ to lateral inhibition [21,22]. 
To date, XCoe2 is the only transcription factor whose ability
to induce ectopic neurons in the epidermis is highly sensi-
tive to lateral inhibition. Overexpression of the bHLH
protein XASH-3 (Xenopus AS-C homologue-3) also results in
a scattered pattern of ectopic neurons [26], but in contrast to
XCoe2, XASH-3 promotes neurogenesis only in the neural
plate [28,29]. Because X-ngnr-1 (or Xcoe2) and XASH-3 are
expressed in largely non-overlapping groups of cells in the
neural plate ([10,28–30] and this report), it is possible that
different pathways of neuronal specification operate during
Xenopus early embryogenesis, involving different genes with
similar proneural functions, as is the case in Drosophila for
AS-C and atonal. X-Myt, a zinc-finger transcriptional activa-
tor, has been proposed to cooperate with the proneural
bHLH proteins X-Ngnr-1 and XASH-3 to promote their
proneural activity in selected progenitor cells, although prob-
ably not by directly interfering with the lateral inhibitory
circuit [23]. Whether X-Myt plays a role in the positive-feed-
back regulation of X-ngnr-1 remains to be examined.
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Figure 7
Model for the transcriptional interactions
controlling the specification of primary
neurons in Xenopus. X-ngnr-1, Xcoe2 and
XNeuroD are sequentially activated in primary
neuron progenitors. Expression of X-ngnr-1
renders cells competent to adopt a neural fate
[10]. Expression of X-Ngnr-1 above a certain
threshold leads to activation of Xcoe2 in
selected progenitor cells. XCoe2 activity is
required for stable commitment of these cells
to a neural fate via the maintenance of
Delta–Notch signalling and a positive-
feedback regulation of X-ngnr-1 expression.
XCoe2 is also required for the expression of
differentiation genes such as XNeuroD.
Whether this activation is direct or is through
the maintenance of high levels of X-ngnr-1
expression, or both, remains to be determined.
The time window between activation of Xcoe2
and XNeuroD, at stages 12 and 13.5,
respectively, during which the majority of
primary neurons are in the last G2 phase
preceding their exit from the mitotic cycle [1],
might allow neuron progenitors to respond to
spatially and temporally regulated
environmental cues.
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A family of HLH transcription factors involved in vertebrate
neural development
Xcoe2 was isolated on the basis of sequence homology to
Drosophila col and rodent EBF/Olf-1. Using the same
strategy, two new mouse genes have been isolated
recently [15,17]: EBF-2/OE3 and EBF-3/OE2, closely
related to EBF/Olf-1 (henceforth renamed EBF-1/OE1).
The three mouse genes show largely overlapping expres-
sion patterns during embryonic development of the
nervous system, in early post-mitotic cells in the spinal
cord, midbrain and specific areas of the forebrain, which
might explain why no obvious neuronal phenotype was
identified in EBF-1 knockout mice [31]. The transient
expression of EBF/OE in cells withdrawing from the
mitotic cycle in the spinal cord is reminiscent of that
observed for Xcoe2 during primary neurogenesis. XCoe2,
the EBFs and Col thus define a family of transcription
factors expressed during neuronal specification (this
report and M.C., data not shown) [15,17] characterised by
a new type of DNA-binding domain associated with an
HLH motif. We refer to these proteins under the generic
name of Coe transcription factors. 
HLH motifs, which mediate homodimerisation and/or
heterodimerisation, have so far been found in two types of
transcription factor: bHLH proteins, all of which bind to
similar DNA sequences collectively designated E boxes;
and proteins lacking the basic region. This second group
of proteins has been shown to antagonise the function of
bHLH proteins by forming heterodimers that are unable
to bind DNA. Although there is no evidence so far for het-
erodimer formation between Coe proteins and other types
of HLH proteins, it has been established previously that
EBF-1 binds to DNA as a dimer [12,14,32,33]. Further-
more, all three mouse Coe proteins are able to dimerise
with themselves and with the other members of the family
[17]. Recently, EBF-1 and the bHLH protein E47 have
been shown to collaborate to induce expression of the
early B-lymphocyte-specific gene λ5. In this case, the
synergy between the two transcription factors relies upon
the multiplicity of their binding sites in the λ5 promoter
rather than synergistic protein–protein interactions [33].
Complex families of bHLH transcription factors related to
the Drosophila proneural proteins AS-C or Atonal (the
NeuroD, Neurogenin or MATH families) have been iden-
tified recently in the mouse and chicken [34–37]. Thus,
there are already a large number of putative neuronal
determination or differentiation factors with which Coe
proteins potentially interact, in both the central and
peripheral nervous systems. Like the EBFs [15,17], the
several neurogenin genes in the mouse also form a family
with partly overlapping expression patterns in the spinal
cord, the brain, neural crest cells or the olfactory placodes,
which might activate NeuroD in different sublineages
[34,35]. It remains a challenging question whether interac-
tion between different Coe proteins and bHLH proteins
in the nervous system is limited to directional cascades of
transcriptional activation or involves synergistic interac-
tions on specific promoters to activate subsets of genes in
a combinatorial fashion.
Conclusions
This analysis reveals an important role for XCoe2, an
HLH transcription factor (of the Coe family), in the speci-
fication of primary neurons in Xenopus. Both the temporal
pattern of Xcoe2 expression and the requirement for Xcoe2
in order for selected progenitor cells to become committed
to a neural fate define a new step in primary neurogenesis:
a switch between neural competence (conferred by the
proneural-like gene X-ngnr-1) and neuronal differentiation
(Figure 7). Like Xcoe2 and zfcoe2 in the zebrafish (L.B-C.,
unpublished observations), EBF/OE genes in the mouse
are transiently expressed in differentiating neurons in the
CNS, in the zone extending from the midbrain to the
spinal cord and in specific regions of the anterior brain
[15]. These data are consistent with a conserved role for
Coe transcription factors in the control of neuronal differ-
entiation in the vertebrate CNS.
Materials and methods 
Isolation of cDNA
Random-primed cDNA was prepared from embryonic stage 25
Xenopus RNA. Degenerate oligonucleotide primers were designed,
based on conserved amino-acid sequences within the DNA-binding
domain of the Drosophila Col and mouse EBF proteins [15]: 3′ degen-
erate primer 5′TT(A/G)TT(A/G)TGNAC(A/G)AACAT(A/G)TT(A/G)TC3′
corresponds to the peptide sequence DNMFVHNN (in single-letter
amino-acid code) and 5′ degenerate primer 5′GCNCA(C/T)-
TT(T/C)GA(A/G)AA(A/G)CA(A/G)CC3′ corresponds to the peptide
sequence AHFEKQP. These primers were used for PCR amplification
under conditions described by the manufacturer (Cetus). Amplification
was for 30 cycles at 94°C for 1 min, 50°C for 2 min and 72°C for 3 min.
PCR products of the appropriate size (560 bp) were purified by gel
electrophoresis, subcloned and sequenced. The fragment correspond-
ing to the most abundant class of PCR products was used as a probe
to screen a stage 17 embryo cDNA library in λgt10. Six cDNAs that
encode Col/EBF-related proteins were identified in a screen of 106
colonies. The largest cDNA (2.2 kb), which contains a complete open
reading frame, was subcloned in pBSKS, and its nucleotide sequence
was determined using the Pharmacia sequencing kit. The GenBank
Accession number for the Xcoe2 sequence is AF041138.
In situ hybridisation, antibody staining and histology
The 2.2 kb Xcoe2 cDNA, cloned in pBSKS, was linearised with XbaI
and transcribed with T3 RNA polymerase to generate a digoxigenin-
labelled antisense RNA probe. The 5′ Xcoe2 probe was generated
using the 5′ EcoRI–Aflll Xcoe2 cDNA fragment (686 bp) cloned in
pBSKS. The XNeuroD, X-Dl1 and N-tubulin probes were prepared as
described [9,26,38]. Embryos were staged according to Nieuwkoop
and Faber [39]. Whole-mount in situ hybridisation was performed
using the procedure of Harland [40], with the following modifications:
pre-blocking of the alkaline-phosphatase-conjugated digoxigenin anti-
body [41]; incubation of embryos for 1 h at room temperature in block-
ing solution (Boehringer Mannheim); and staining with BM purple
(Boehringer Mannheim). Double-labelling whole-mount in situ hybridis-
ation was performed as described [22], using digoxigenin-labelled X-
Dl1 and fluorescein-labelled N-tubulin RNA probes. Embryos were
stained with anti-N-CAM antibody (1/20 dilution) as described [42],
following in situ hybridisation or immunohistochemistry; some embryos
Research Paper  A new type of HLH factor in the neurogenic cascade Dubois et al.    207
were cleared in 2:1 benzyl benzoat : benzyl alcohol. Sections (10 µm)
were made from stained paraffin-embedded embryos.
RNA synthesis and injection
The entire Xcoe2 cDNA was cloned into the EcoRI site of the RN3
vector [43]. To synthesise RNAs coding for a truncated XCoe2 protein
lacking part of the DNA-binding domain (XCoe2∆DBD), the PstI–XhoI 3′
fragment of Xcoe2 (corresponding to amino acids 303–589) was
cloned in-frame into the StuI site of the plasmid pCS2+MT [28].
Capped Xcoe2 and Xcoe2∆DBD mRNAs were transcribed using the T3
and SP6 Cap-Scribe, respectively (Boehringer Mannheim). X-ngnr-1
[10], X-Dl1dn and NLSlacZ [21] RNAs were prepared as originally
described, and were injected at a concentration of 2–100 pg/nl, in a
volume of 5 nl, into a single blastomere of two- to eight-cell embryos. In
most experiments, lacZ mRNA was co-injected as a marker; injection of
lacZ mRNA alone was used as a control. Histochemical staining for
β galactosidase was used to visualise the distribution of injected
mRNAs. Embryos were collected at either the neural plate stage (stage
12.5–15) or tailbud stage (stage 25–28) and subjected to in situ
hybridisation as described above. 
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